All Posts Tagged Tag: ‘Afrezza’

Inhaled Insulin Afrezza Receives FDA Approval

Could this be the end of daily insulin shots for some of the nearly 25.8 million people in the United States — 8.3 percent of the population — who suffer from diabetes? The U.S. Food and Drug Administration announced Friday the approval of Afrezza, a rapid-acting inhaled insulin used in the treatment of diabetes. The medicine is meant be used …

Read More